Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022

Abstract Introduction Antimicrobial resistance is a global issue, with the World Health Organization identifying it as one of the greatest threats to public health, with an estimated 4.95 million deaths linked to bacterial AMR in 2019. Our study aimed to determine the prevalence of mortality among m...

Full description

Saved in:
Bibliographic Details
Main Authors: Sharifa Ezat WP, M Norhidayah, Muhammad Nur Amir AR
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-024-10338-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595002647117824
author Sharifa Ezat WP
M Norhidayah
Muhammad Nur Amir AR
author_facet Sharifa Ezat WP
M Norhidayah
Muhammad Nur Amir AR
author_sort Sharifa Ezat WP
collection DOAJ
description Abstract Introduction Antimicrobial resistance is a global issue, with the World Health Organization identifying it as one of the greatest threats to public health, with an estimated 4.95 million deaths linked to bacterial AMR in 2019. Our study aimed to determine the prevalence of mortality among multidrug-resistant organism (MDRO)-infected patients in state hospitals and major specialist hospitals and to identify risk factors that could be associated with mortality outcomes. Methods This is a cross-sectional study performed at 28 hospitals under the Ministry of Health, Malaysia, involved in the National Surveillance of Multidrug-Resistant Organism, which surveys 6 MDROs (Acinetobacter baumanii, extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae, carbapenem-resistant Entrobacterales (CRE), methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE)). Results In terms of mortality, 9.6% (n = 951) of the patients died overall, whereas 90.4% (n = 8931) of the patients survived. Healthcare-acquired infection (HCAI) poses a high risk of mortality, with an adjusted odds ratio (aOR) of 2.91 (95% CI: 2.15–3.94). The presence of sterile specimens was significantly associated with increased mortality risk (aOR: 2.33, 95% CI: 2.02–2.68). Gram-negative bacteria had a greater mortality risk (aOR 1.63 95% CI: 1.37–1.93), whereas Acinetobacter baumanii had the highest prevalence of 30.7% (3033) among the 6 MDRO organisms isolated. Patients in medical-based departments had a greater mortality risk (aOR: 1.47, 95% CI: 1.22–1.75). Conclusion HCAIs, Gram-negative bacteria, sterile specimens, medical-based departments and state hospitals have been shown to be associated with increased mortality risk in patients with MDRO infections. Improved surveillance and reporting mechanisms are necessary to better understand the burden of MDRO infections and guide research funding allocation.
format Article
id doaj-art-cbdcad1fff0a46cbbe8df2ea62410b85
institution Kabale University
issn 1471-2334
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-cbdcad1fff0a46cbbe8df2ea62410b852025-01-19T12:11:51ZengBMCBMC Infectious Diseases1471-23342025-01-0125111210.1186/s12879-024-10338-8Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022Sharifa Ezat WP0M Norhidayah1Muhammad Nur Amir AR2Department of Public Health Medicine, Faculty of Medicine, National University of Malaysia, Federal Territory of Kuala LumpurDepartment of Public Health Medicine, Faculty of Medicine, National University of Malaysia, Federal Territory of Kuala LumpurDepartment of Public Health Medicine, Faculty of Medicine, National University of Malaysia, Federal Territory of Kuala LumpurAbstract Introduction Antimicrobial resistance is a global issue, with the World Health Organization identifying it as one of the greatest threats to public health, with an estimated 4.95 million deaths linked to bacterial AMR in 2019. Our study aimed to determine the prevalence of mortality among multidrug-resistant organism (MDRO)-infected patients in state hospitals and major specialist hospitals and to identify risk factors that could be associated with mortality outcomes. Methods This is a cross-sectional study performed at 28 hospitals under the Ministry of Health, Malaysia, involved in the National Surveillance of Multidrug-Resistant Organism, which surveys 6 MDROs (Acinetobacter baumanii, extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae, carbapenem-resistant Entrobacterales (CRE), methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE)). Results In terms of mortality, 9.6% (n = 951) of the patients died overall, whereas 90.4% (n = 8931) of the patients survived. Healthcare-acquired infection (HCAI) poses a high risk of mortality, with an adjusted odds ratio (aOR) of 2.91 (95% CI: 2.15–3.94). The presence of sterile specimens was significantly associated with increased mortality risk (aOR: 2.33, 95% CI: 2.02–2.68). Gram-negative bacteria had a greater mortality risk (aOR 1.63 95% CI: 1.37–1.93), whereas Acinetobacter baumanii had the highest prevalence of 30.7% (3033) among the 6 MDRO organisms isolated. Patients in medical-based departments had a greater mortality risk (aOR: 1.47, 95% CI: 1.22–1.75). Conclusion HCAIs, Gram-negative bacteria, sterile specimens, medical-based departments and state hospitals have been shown to be associated with increased mortality risk in patients with MDRO infections. Improved surveillance and reporting mechanisms are necessary to better understand the burden of MDRO infections and guide research funding allocation.https://doi.org/10.1186/s12879-024-10338-8Healthcare-acquired infectionsAntimicrobial resistanceBacteraemiaHospital mortality
spellingShingle Sharifa Ezat WP
M Norhidayah
Muhammad Nur Amir AR
Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022
BMC Infectious Diseases
Healthcare-acquired infections
Antimicrobial resistance
Bacteraemia
Hospital mortality
title Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022
title_full Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022
title_fullStr Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022
title_full_unstemmed Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022
title_short Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022
title_sort factors associated with multidrug resistant organism mdro mortality an analysis from the national surveillance of multidrug resistant organism 2018 2022
topic Healthcare-acquired infections
Antimicrobial resistance
Bacteraemia
Hospital mortality
url https://doi.org/10.1186/s12879-024-10338-8
work_keys_str_mv AT sharifaezatwp factorsassociatedwithmultidrugresistantorganismmdromortalityananalysisfromthenationalsurveillanceofmultidrugresistantorganism20182022
AT mnorhidayah factorsassociatedwithmultidrugresistantorganismmdromortalityananalysisfromthenationalsurveillanceofmultidrugresistantorganism20182022
AT muhammadnuramirar factorsassociatedwithmultidrugresistantorganismmdromortalityananalysisfromthenationalsurveillanceofmultidrugresistantorganism20182022